QTREX Quantum Ltd.

QTEXTechnology · Computer HardwareVisit siteCIK 0001837493

Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.): $51.0M
Price: $0.9155
% Change (Daily % change from the live per-ticker quote feed.): +6.96%
Volume: 2.2M

About

QTREX Quantum Ltd. is an Israel-based specialized medical device firm. Its core activities encompass the research, development, manufacturing, and commercialization of unique life support technologies aimed at treating acute respiratory failure. The company provides the INSPIRA ART100, a vital life support system designed for cardiopulmonary bypass procedures lasting up to six hours. Additionally, it offers the HYLA blood sensor, engineered to deliver real-time sampling and analysis of critical blood parameter measurements. Founded in 2018, the company previously operated as Inspira Technologies Oxy B.H.N. Ltd. before rebranding to QTREX Quantum Ltd. in May 2026. Its primary operations are headquartered in Ra'anana, Israel.

Quick stats

Shares outstanding55.7M

Computed float36.3M

Float / shares65.2%

Key info

SectorTechnology

IndustryComputer Hardware

CIK0001837493

Websitehttps://www.q-trex.com

AI Summary

AI-generated

1/33

3d ago

standardbearishoffering

QTREX Announces Pricing of a $10 Million Registered Direct Offering of Ordinary Shares

QTREX priced a registered direct offering of 11.11 million ordinary shares for aggregate gross proceeds of approximately $10 million.

The financing was led by an existing institutional investor and includes a new global institutional investor, with A.G.P./Alliance Global Partners acting as sole placement agent.

The company intends to use the net proceeds for working capital and general corporate purposes, with closing expected on or about August 21, 2026.

Red flags

use of proceeds is 'working capital and general corporate purposes' (signals cash burn)